Michelle Bentata
Impact in
- Virology top 5%
- HIV Research and Treatment
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- HIV/AIDS drug development and treatment 5
- Oncology 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Claude Degott (2 shared papers)Dominique Pessayre (2 shared papers)O Nouël (2 shared papers)Jean‐Philippe Miguet (2 shared papers)Jean‐Pierre Benhamou (2 shared papers)B Rueff (2 shared papers)Dominique Costagliola (4 shared papers)Clotilde Allavena (2 shared papers)
- Journals
- AIDS (4 papers)Journal of Clinical Densitometry (1 paper)HIV Clinical Trials (1 paper)Antiviral Therapy (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Michelle Bentata
16 papers receiving 592 citations
Peers
Comparison fields: 5 of 54
- Virology 137
- Hepatology 113
- Pharmacology 133
- Infectious Diseases 239
- Emergency Medicine 100
Countries citing papers authored by Michelle Bentata
This map shows the geographic impact of Michelle Bentata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Bentata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Bentata more than expected).
Fields of papers citing papers by Michelle Bentata
This network shows the impact of papers produced by Michelle Bentata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Bentata. The network helps show where Michelle Bentata may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Bentata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 156 | |
| 2 | Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. | 1977 | 98 |
| 3 | 2001 | 90 | |
| 4 | 1977 | 81 | |
| 5 | 2012 | 37 | |
| 6 | 2013 | 33 | |
| 7 | 2005 | 33 | |
| 8 | 2005 | 28 | |
| 9 | 2012 | 17 | |
| 10 | 2013 | 14 | |
| 11 | 2009 | 9 | |
| 12 | 2009 | 7 | |
| 13 | 2001 | 6 | |
| 14 | 1995 | 4 | |
| 15 | 2009 | 3 | |
| 16 | [Sarcoidosis in husband and wife]. | 1991 | 1 |
About Michelle Bentata
Michelle Bentata is a scholar working on Infectious Diseases, Oncology, Epidemiology, Emergency Medicine and Pharmacology, having authored 16 papers that have together received 617 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), HIV-related health complications and treatments (3 papers), Bone and Joint Diseases (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Virology (137 citations), Hepatology (113 citations), Pharmacology (133 citations), Infectious Diseases (239 citations) and Emergency Medicine (100 citations). Michelle Bentata has collaborated with scholars based in France and United States. Frequent co-authors include Claude Degott, Dominique Pessayre, O Nouël, Jean‐Philippe Miguet, Jean‐Pierre Benhamou, B Rueff, Dominique Costagliola, Clotilde Allavena, Rémi Lancar and Sophie Grabar. Their work appears in journals such as AIDS, Journal of Clinical Densitometry, HIV Clinical Trials, Antiviral Therapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.